Home › Calculator › HBIO Dividend Calculator 2026
HBIO Dividend DRIP Calculator 2026
30.17% YieldHealthcareHarvard Bioscience, Inc. · NASDAQ
Price: $6.63 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When HBIO pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your HBIO snowball 📈
$10,000 in HBIO → $16.26M in 10 years · $1,168,889.77/month
About Harvard Bioscience, Inc. (HBIO) — Dividend Analysis 2026
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Compare HBIO with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HBIO DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HBIO position with:
🌍 HBIO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HBIO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 30.17% | 27.37% | $3,017 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 25.64% | 22.84% | $2,564 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 24.14% | 21.34% | $2,414 / yr |
| 🇬🇧 UK ISA | 0% | 30.17% | 27.37% | $3,017 / yr |
| 🇬🇧 UK Taxable | 8.75% | 27.53% | 24.73% | $2,753 / yr |
| 🇨🇦 TFSA | 0% | 30.17% | 27.37% | $3,017 / yr |
| 🇨🇦 CA Taxable | 25% | 22.63% | 19.83% | $2,263 / yr |
| 🇦🇺 Super (pension) | 15% | 25.64% | 22.84% | $2,564 / yr |
| 🇦🇺 AU Taxable | 30% | 21.12% | 18.32% | $2,112 / yr |
| 🇩🇪 DE Taxable | 26.375% | 22.21% | 19.41% | $2,221 / yr |
| 🇫🇷 FR Taxable | 30% | 21.12% | 18.32% | $2,112 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HBIO Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HBIO Dividend Payment Schedule
HBIO pays quarterly — 4 times per year. Next ex-div: TBD.
📊 HBIO vs Healthcare Benchmarks
How HBIO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HBIO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HBIO Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-09 | 16,556 | — | — | ||
| A-Award | 2026-06-09 | 16,556 | — | — | ||
| A-Award | 2026-06-09 | 16,556 | — | — | ||
| A-Award | 2026-06-09 | 16,556 | — | — | ||
| A-Award | 2026-06-09 | 16,556 | — | — | ||
| A-Award | 2026-03-20 | 30,000 | — | — | ||
| Buy | 2026-03-16 | 5,000 | $5.00 | $25.0K | ||
| A-Award | 2026-03-20 | 75,000 | — | — | ||
| Buy | 2026-03-17 | 10,000 | $4.87 | $48.7K | ||
| Buy | 2026-03-17 | 8,475 | $4.85 | $41.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where HBIO earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HBIO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Harvard Bioscience, Inc. (HBIO) is currently trading at $6.63, 92% below its 52-week high. The current dividend yield is 30.17% based on an annual payout of $2.00 per share.
HBIO (Harvard Bioscience, Inc.) — 30.17% Dividend Yield Analysis
Harvard Bioscience, Inc. (HBIO) is a healthcare stock currently trading at $6.63 with a dividend yield of 30.17%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (30.17%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.